Document is current
Any future updates will be listed below
-
Authors
Ferrari, Mathieu https://orcid.org/0000-0001-8535-7348
Parekh, Farhaan
Maciocia, Paul https://orcid.org/0000-0002-9757-8073
Horna, Pedro
Thomas, Simon
Sewell, Andrew K. https://orcid.org/0000-0003-3194-3135
Pule, Martin https://orcid.org/0000-0002-8347-9867
- License Information
-
More Information
Article History
Received: 13 October 2024
Accepted: 15 January 2025
First Online: 29 January 2025
Competing interests
: M.F., S.T., F.P., and M.P. are employees of and hold equity in Autolus Therapeutics. Patent applications have been filed relating to the use of TRBC1 and TRBC2 targeting agents. P.M. holds equities in Autolus Therapeutics. The remaining authors declare no competing interests.
